Results 161 to 170 of about 665,097 (197)
Dose-finding study of triptorelin acetate for prevention of a premature LH surge in IVF: a prospective, randomized, double-blind, placebo-controlled study. [PDF]
Human Reproduction, 2000 Gonadotrophin-releasing hormone agonists (GnRHa) are routinely used in IVF programmes to prevent an unwanted LH surge and consequent ovulation. Despite its widespread use in IVF, a convincing dose recommendation for GnRHa in IVF does not exist. In our opinion, the lowest possible dose of GnRHa should be used.
R Schats, J Schoemaker, C B Lambalk
exaly +3 more sources
Pregnancy and Birth After GnRH Agonist Treatment for Induction of Final Oocyte Maturation in a Woman Undergoing Ovarian Stimulation for ICSI, Using a GnRH Antagonist (Orgalutran/Antagon) to Prevent a Premature LH Surge: A Case Report [PDF]
Journal of Assisted Reproduction and Genetics, 2001 Bart C J M Fauser +2 more
exaly +4 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Reproductive BioMedicine Online, 2003
Gonadotrophin-releasing hormone antagonists are effective and safe in preventing premature LH surges, a leading cause of cycle cancellation or failure during assisted conception. Two studies assessed two administration regimens for cetrorelix (as Cetrotide): the multiple-dose (MD, 0.25 mg/day, n = 1066) and single-dose (SD, 3 mg, n = 541) protocols ...
F, Olivennes +4 more
openaire +2 more sources
Gonadotrophin-releasing hormone antagonists are effective and safe in preventing premature LH surges, a leading cause of cycle cancellation or failure during assisted conception. Two studies assessed two administration regimens for cetrorelix (as Cetrotide): the multiple-dose (MD, 0.25 mg/day, n = 1066) and single-dose (SD, 3 mg, n = 541) protocols ...
F, Olivennes +4 more
openaire +2 more sources
Journal of In Vitro Fertilization and Embryo Transfer, 1989
Recognizing the association between plasma progesterone (P) and an imminent LH surge, we investigated the frequency of P elevation in our stimulation protocol (clomiphene citrate-human menopausal gonadotropins). P was measured retrospectively on the day before, the day of, and the day after human chorionic gonadotropin hCG administration. The means +/-
J, Blankstein +4 more
openaire +2 more sources
Recognizing the association between plasma progesterone (P) and an imminent LH surge, we investigated the frequency of P elevation in our stimulation protocol (clomiphene citrate-human menopausal gonadotropins). P was measured retrospectively on the day before, the day of, and the day after human chorionic gonadotropin hCG administration. The means +/-
J, Blankstein +4 more
openaire +2 more sources
Archives of Gynecology and Obstetrics
Progesterone can be used instead of GnRH agonists and antagonists in order to avert a premature LH surge during controlled ovarian stimulation (COS) protocol. Nonetheless, there is limited knowledge regarding its utilization. Thus, this study compared the effects of progesterone and GnRH antagonists (GnRH-ant) on premature LH surges and assisted ...
Aida Najafian +2 more
exaly +3 more sources
Progesterone can be used instead of GnRH agonists and antagonists in order to avert a premature LH surge during controlled ovarian stimulation (COS) protocol. Nonetheless, there is limited knowledge regarding its utilization. Thus, this study compared the effects of progesterone and GnRH antagonists (GnRH-ant) on premature LH surges and assisted ...
Aida Najafian +2 more
exaly +3 more sources
Akusherstvo i ginekologiia, 2002
The author present a different stimulation regiment in assisted reproductive technologies (ARTs). Gonadotropin-releasing hormone antagonist (GnRH-antagonist) introduces a new treatment option for patients undergoing ovarian stimulation for IVF or ICSI. This protocol is safe (with reduction of OHSS risk), short and simple.
openaire +1 more source
The author present a different stimulation regiment in assisted reproductive technologies (ARTs). Gonadotropin-releasing hormone antagonist (GnRH-antagonist) introduces a new treatment option for patients undergoing ovarian stimulation for IVF or ICSI. This protocol is safe (with reduction of OHSS risk), short and simple.
openaire +1 more source
Reply: “Decision Thresholds” for premature LH surges?
Fertility and Sterility, 2007Astrid E.P. Cantineau, Bernard J. Cohlen
openaire +1 more source
Luteal-phase ovarian stimulation: a new sight of eliminating premature LH surge and OHSS
Fertility and Sterility, 2013K. Yanping +5 more
openaire +1 more source
“Decision thresholds” for premature LH surges?
Fertility and Sterility, 2007openaire +1 more source